These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 9111502)
1. Priming of eosinophil adhesion in patients with birch pollen allergy during pollen season: effect of immunotherapy. Håkansson L; Heinrich C; Rak S; Venge P J Allergy Clin Immunol; 1997 Apr; 99(4):551-62. PubMed ID: 9111502 [TBL] [Abstract][Full Text] [Related]
2. Sublingual allergen immunotherapy with a liquid birch pollen product in patients with seasonal allergic rhinoconjunctivitis with or without asthma. Pfaar O; Bachert C; Kuna P; Panzner P; Džupinová M; Klimek L; van Nimwegen MJ; Boot JD; Yu D; Opstelten DJE; de Kam PJ J Allergy Clin Immunol; 2019 Mar; 143(3):970-977. PubMed ID: 30508538 [TBL] [Abstract][Full Text] [Related]
3. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). Möller C; Dreborg S; Ferdousi HA; Halken S; Høst A; Jacobsen L; Koivikko A; Koller DY; Niggemann B; Norberg LA; Urbanek R; Valovirta E; Wahn U J Allergy Clin Immunol; 2002 Feb; 109(2):251-6. PubMed ID: 11842293 [TBL] [Abstract][Full Text] [Related]
4. A pre-seasonal birch/hazel sublingual immunotherapy can improve the outcome of grass pollen injective treatment in bisensitized individuals. A case-referent, two-year controlled study. Cirla AM; Cirla PE; Parmiani S; Pecora S Allergol Immunopathol (Madr); 2003; 31(1):31-43. PubMed ID: 12573207 [TBL] [Abstract][Full Text] [Related]
5. Immunotherapy abrogates the generation of eosinophil and neutrophil chemotactic activity during pollen season. Rak S; Håkanson L; Venge P J Allergy Clin Immunol; 1990 Nov; 86(5):706-13. PubMed ID: 2229837 [TBL] [Abstract][Full Text] [Related]
6. The effect of immunotherapy on T-cell subsets in peripheral blood and bronchoalveolar lavage fluid in pollen-allergic patients. Rak S; Hallden G; Sörenson S; Margari V; Scheynius A Allergy; 1993 Aug; 48(6):460-5. PubMed ID: 8238803 [TBL] [Abstract][Full Text] [Related]
7. The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients. Rak S; Löwhagen O; Venge P J Allergy Clin Immunol; 1988 Sep; 82(3 Pt 1):470-80. PubMed ID: 3170995 [TBL] [Abstract][Full Text] [Related]
8. Comparison of nasal immunohistology in patients with seasonal rhinoconjunctivitis treated with topical steroids or specific allergen immunotherapy. Rak S; Heinrich C; Scheynius A Allergy; 2005 May; 60(5):643-9. PubMed ID: 15813810 [TBL] [Abstract][Full Text] [Related]
9. Accelerated Up-Dosing of Subcutaneous Immunotherapy with a Registered Allergoid Birch Pollen Preparation. Buczyłko K; van der Werf JF; Boot D; van Ree R Int Arch Allergy Immunol; 2017; 172(3):183-186. PubMed ID: 28380494 [TBL] [Abstract][Full Text] [Related]
10. The effect of immunotherapy on eosinophil accumulation and production of eosinophil chemotactic activity in the lung of subjects with asthma during natural pollen exposure. Rak S; Björnson A; Håkanson L; Sörenson S; Venge P J Allergy Clin Immunol; 1991 Dec; 88(6):878-88. PubMed ID: 1744358 [TBL] [Abstract][Full Text] [Related]
11. A double-blinded, comparative study of the effects of short preseason specific immunotherapy and topical steroids in patients with allergic rhinoconjunctivitis and asthma. Rak S; Heinrich C; Jacobsen L; Scheynius A; Venge P J Allergy Clin Immunol; 2001 Dec; 108(6):921-8. PubMed ID: 11742269 [TBL] [Abstract][Full Text] [Related]
12. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma. Roberts G; Hurley C; Turcanu V; Lack G J Allergy Clin Immunol; 2006 Feb; 117(2):263-8. PubMed ID: 16461125 [TBL] [Abstract][Full Text] [Related]
14. Allergen specific immunotherapy attenuates early and late phase reactions in lower airways of birch pollen asthmatic patients: a double blind placebo-controlled study. Arvidsson MB; Löwhagen O; Rak S Allergy; 2004 Jan; 59(1):74-80. PubMed ID: 14674937 [TBL] [Abstract][Full Text] [Related]
15. Oral immunotherapy of children with rhinoconjunctivitis due to birch pollen allergy. A double blind study. Möller C; Dreborg S; Lanner A; Björkstén B Allergy; 1986 May; 41(4):271-9. PubMed ID: 3530030 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis. Pauli G; Larsen TH; Rak S; Horak F; Pastorello E; Valenta R; Purohit A; Arvidsson M; Kavina A; Schroeder JW; Mothes N; Spitzauer S; Montagut A; Galvain S; Melac M; André C; Poulsen LK; Malling HJ J Allergy Clin Immunol; 2008 Nov; 122(5):951-60. PubMed ID: 19000581 [TBL] [Abstract][Full Text] [Related]
17. Immunotherapy With the SQ Tree SLIT-tablet in Adults and Adolescents With Allergic Rhinoconjunctivitis. Mäkelä MJ; Gyllfors P; Valovirta E; Steffensen MA; Grønager PM; Savolainen J; Winther L Clin Ther; 2018 Apr; 40(4):574-586.e4. PubMed ID: 29551533 [TBL] [Abstract][Full Text] [Related]
19. Effect of hyposensitization for tree pollinosis on associated apple allergy. Herrmann D; Henzgen M; Frank E; Rudeschko O; Jäger L J Investig Allergol Clin Immunol; 1995; 5(5):259-67. PubMed ID: 8574432 [TBL] [Abstract][Full Text] [Related]
20. Non-specific airway hyperresponsiveness in mono-sensitive Sicilian patients with allergic rhinitis. Its relationship to total serum IgE levels and blood eosinophils during and out of the pollen season. Di Lorenzo G; Mansueto P; Melluso M; Morici G; Norrito F; Esposito Pellitteri M; Di Salvo A; Colombo A; Candore G; Caruso C Clin Exp Allergy; 1997 Sep; 27(9):1052-9. PubMed ID: 9678837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]